Flywheel Raises $54M in Series D Funding

Flywheel, a Minneapolis, MN-based provider of a medical imaging data and AI platform, raised $54M in Series D funding.

The round was co-led by Novalis LifeSciences LLC and NVentures, NVIDIA’s venture capital arm. Microsoft also participated in the round, along with insiders Invenshure, 8VC, Beringea, Hewlett Packard Enterprise, Intuitive Ventures, iSelect, Gundersen Health System, Seraph, and Great North Ventures. Marijn Dekkers, chairman and founder of Novalis LifeSciences and former CEO of Bayer AG and Thermo Fisher Scientific Inc., will join the company’s board of directors.

The company intends to use the funds to consolidate its growth in two primary markets, public sector healthcare and pharmaceutical companies, while accelerating expansion in other markets including providers, payers, system integrators, and software companies.

Led by CEO Jim Olson, Flywheel provides a medical imaging data and AI platform powering healthcare innovation through streamlined medical imaging data management, curation and analysis for accelerated research and AI development. The company offers comprehensive solutions for pharma companies, providers, payers, system integrators, AI developers and academic medical centers to get optimum value out of their data assets.  

FinSMEs

03/07/2023